TargetMacrophage migration inhibitory factor(Homo sapiens (Human))
Yamanouchi Pharmaceutical
Curated by ChEMBL
Yamanouchi Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 38nMAssay Description:Inhibitory activity against tautomerase macrophage migration inhibitory factor (MIF)More data for this Ligand-Target Pair
TargetMacrophage migration inhibitory factor(Homo sapiens (Human))
Yamanouchi Pharmaceutical
Curated by ChEMBL
Yamanouchi Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 280nMAssay Description:Inhibitory activity against tautomerase macrophage migration inhibitory factor (MIF)More data for this Ligand-Target Pair
TargetMacrophage migration inhibitory factor(Homo sapiens (Human))
Yamanouchi Pharmaceutical
Curated by ChEMBL
Yamanouchi Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 470nMAssay Description:Inhibitory activity against tautomerase macrophage migration inhibitory factor (MIF)More data for this Ligand-Target Pair
TargetMacrophage migration inhibitory factor(Homo sapiens (Human))
Yamanouchi Pharmaceutical
Curated by ChEMBL
Yamanouchi Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 500nMAssay Description:Inhibitory activity against tautomerase macrophage migration inhibitory factor (MIF)More data for this Ligand-Target Pair
TargetMacrophage migration inhibitory factor(Homo sapiens (Human))
Yamanouchi Pharmaceutical
Curated by ChEMBL
Yamanouchi Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 550nMAssay Description:Inhibitory activity against tautomerase macrophage migration inhibitory factor (MIF)More data for this Ligand-Target Pair
TargetMacrophage migration inhibitory factor(Homo sapiens (Human))
Yamanouchi Pharmaceutical
Curated by ChEMBL
Yamanouchi Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 1.50E+3nMAssay Description:Inhibitory activity against tautomerase macrophage migration inhibitory factor (MIF)More data for this Ligand-Target Pair
TargetMacrophage migration inhibitory factor(Homo sapiens (Human))
Yamanouchi Pharmaceutical
Curated by ChEMBL
Yamanouchi Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 1.60E+3nMAssay Description:Inhibitory activity against tautomerase macrophage migration inhibitory factor (MIF)More data for this Ligand-Target Pair
TargetMacrophage migration inhibitory factor(Homo sapiens (Human))
Yamanouchi Pharmaceutical
Curated by ChEMBL
Yamanouchi Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 2.10E+3nMAssay Description:Inhibitory activity against tautomerase macrophage migration inhibitory factor (MIF)More data for this Ligand-Target Pair
TargetMacrophage migration inhibitory factor(Homo sapiens (Human))
Yamanouchi Pharmaceutical
Curated by ChEMBL
Yamanouchi Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 2.60E+3nMAssay Description:Inhibitory activity against tautomerase macrophage migration inhibitory factor (MIF)More data for this Ligand-Target Pair
TargetMacrophage migration inhibitory factor(Homo sapiens (Human))
Yamanouchi Pharmaceutical
Curated by ChEMBL
Yamanouchi Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 2.90E+3nMAssay Description:Inhibitory activity against tautomerase macrophage migration inhibitory factor (MIF)More data for this Ligand-Target Pair
TargetMacrophage migration inhibitory factor(Homo sapiens (Human))
Yamanouchi Pharmaceutical
Curated by ChEMBL
Yamanouchi Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 3.10E+3nMAssay Description:Inhibitory activity against tautomerase macrophage migration inhibitory factor (MIF)More data for this Ligand-Target Pair
TargetMacrophage migration inhibitory factor(Homo sapiens (Human))
Yamanouchi Pharmaceutical
Curated by ChEMBL
Yamanouchi Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 4.30E+3nMAssay Description:Inhibitory activity against tautomerase macrophage migration inhibitory factor (MIF)More data for this Ligand-Target Pair
TargetMacrophage migration inhibitory factor(Homo sapiens (Human))
Yamanouchi Pharmaceutical
Curated by ChEMBL
Yamanouchi Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 5.80E+3nMAssay Description:Inhibitory activity against tautomerase macrophage migration inhibitory factor (MIF)More data for this Ligand-Target Pair
TargetMacrophage migration inhibitory factor(Homo sapiens (Human))
Yamanouchi Pharmaceutical
Curated by ChEMBL
Yamanouchi Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 6.20E+3nMAssay Description:Inhibitory activity against tautomerase macrophage migration inhibitory factor (MIF)More data for this Ligand-Target Pair
TargetMacrophage migration inhibitory factor(Homo sapiens (Human))
Yamanouchi Pharmaceutical
Curated by ChEMBL
Yamanouchi Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 7.40E+3nMAssay Description:Inhibitory activity against tautomerase macrophage migration inhibitory factor (MIF)More data for this Ligand-Target Pair
Affinity DataIC50: 12nMAssay Description:Inhibition of human liver glycogen phosphorylase a in presence of glucoseMore data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma(Homo sapiens (Human))
Takeda Pharmaceutical
Curated by ChEMBL
Takeda Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 12nMAssay Description:Displacement of [3H]-AD-5061 from human GST-tagged PPARgammaMore data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma(Homo sapiens (Human))
Takeda Pharmaceutical
Curated by ChEMBL
Takeda Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 15nMAssay Description:Displacement of [3H]-AD-5061 from human GST-tagged PPARgammaMore data for this Ligand-Target Pair
Affinity DataIC50: 20nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma(Homo sapiens (Human))
Takeda Pharmaceutical
Curated by ChEMBL
Takeda Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 21nMAssay Description:Displacement of [3H]-AD-5061 from human GST-tagged PPARgammaMore data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma(Homo sapiens (Human))
Takeda Pharmaceutical
Curated by ChEMBL
Takeda Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 23nMAssay Description:Displacement of [3H]-AD-5061 from human GST-tagged PPARgammaMore data for this Ligand-Target Pair
Affinity DataIC50: 23nMAssay Description:Inhibition of human liver glycogen phosphorylase a in presence of glucoseMore data for this Ligand-Target Pair
Affinity DataIC50: 26nMAssay Description:Inhibition of human liver glycogen phosphorylase a in presence of glucoseMore data for this Ligand-Target Pair
Affinity DataIC50: 26nMAssay Description:Inhibition of human liver glycogen phosphorylase a in presence of glucoseMore data for this Ligand-Target Pair
Affinity DataIC50: 36nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
Affinity DataIC50: 43nMAssay Description:Inhibition of human liver glycogen phosphorylase a in presence of glucoseMore data for this Ligand-Target Pair
Affinity DataIC50: 44nMAssay Description:Inhibition of CYP2D6 (unknown origin) by fluorescence-based assayMore data for this Ligand-Target Pair
Affinity DataIC50: 48nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
Affinity DataIC50: 63nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
Affinity DataIC50: 68nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
Affinity DataIC50: 68nMAssay Description:Inhibition of CYP2D6 (unknown origin) by fluorescence-based assayMore data for this Ligand-Target Pair
Affinity DataIC50: 160nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
Affinity DataIC50: 250nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
Affinity DataIC50: 260nMAssay Description:Inhibition of human liver glycogen phosphorylase a in absence of glucoseMore data for this Ligand-Target Pair
Affinity DataIC50: <300nMAssay Description:Inhibition of CYP2D6 (unknown origin) by fluorescence-based assayMore data for this Ligand-Target Pair
Affinity DataIC50: 310nMAssay Description:Inhibition of human liver glycogen phosphorylase a in absence of glucoseMore data for this Ligand-Target Pair
Affinity DataIC50: 320nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma(Homo sapiens (Human))
Takeda Pharmaceutical
Curated by ChEMBL
Takeda Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 330nMAssay Description:Displacement of [3H]-AD-5061 from human GST-tagged PPARgammaMore data for this Ligand-Target Pair
Affinity DataIC50: 340nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
Affinity DataIC50: <390nMAssay Description:Inhibition of CYP2D6 (unknown origin) by fluorescence-based assayMore data for this Ligand-Target Pair
Affinity DataIC50: <390nMAssay Description:Inhibition of CYP2D6 (unknown origin) by fluorescence-based assayMore data for this Ligand-Target Pair
Affinity DataIC50: 420nMAssay Description:Inhibition of human liver glycogen phosphorylase a in absence of glucoseMore data for this Ligand-Target Pair
Affinity DataIC50: 420nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
Affinity DataIC50: 430nMAssay Description:Inhibition of human liver glycogen phosphorylase a in absence of glucoseMore data for this Ligand-Target Pair
Affinity DataIC50: 440nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
Affinity DataIC50: 440nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
Affinity DataIC50: 450nMAssay Description:Inhibition of human liver glycogen phosphorylase a in absence of glucoseMore data for this Ligand-Target Pair
Affinity DataIC50: 590nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
Affinity DataIC50: 600nMAssay Description:Inhibition of CYP2D6 (unknown origin) by fluorescence-based assayMore data for this Ligand-Target Pair
Affinity DataIC50: 780nMAssay Description:Inhibition of CYP2D6 (unknown origin) by fluorescence-based assayMore data for this Ligand-Target Pair